Nasus Pharma Ltd. (NYSE: NSRX) will participate in two investor conferences in February and March. The Oppenheimer 36th Annual Healthcare Life Sciences Conference on March 2nd at 10:15 a.m. ET in Miami, FL, and the Citizens Life Sciences Conference on March 11th at 3:25 p.m. ET in Miami, FL. Nasus management will be available for one-on-one meetings during the conferences. Nasus Pharma is a clinical-stage pharmaceutical company developing intranasal powder products like NS002, an intranasal powder Epinephrine product candidate. For more information about Nasus Pharma, visit their website or follow them on Twitter and LinkedIn.

Read more at GlobeNewswire: Nasus Pharma to Participate in Upcoming Investor